Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been ...

Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...

Shares of Novavax NVAX lost nearly 20% on Wednesday after the company announced that the FDA has placed a clinical hold on ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Thursday as the stock market reacts to Taiwan Semiconductor earnings in light of the recent ASML selloff.

Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food a ...

The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...

Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...

Respiratory virus season is underway, but Washington is more prepared than it was last year to protect against some severe ...

Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring. Earlier today, ...